Evidence map›Paper›PMID 35815328›Full record

ArticleJSLS : Journal of the Society of Laparoendoscopic Surgeons

Using the da Vinci X® - System for Esophageal Surgery.

Juri Bergmann, Barbara Lehmann-Dorl, Lars Witt, Heiko Aselmann

Abstract readCase Reports
In one paragraph

Article in JSLS : Journal of the Society of Laparoendoscopic Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juri BergmannGeneral-, Visceral and Vascular Surgery, KRH Klinikum Robert Koch, Gehrden, Germany.
Barbara Lehmann-DorlAnesthesiology, KRH Klinikum Robert Koch, Gehrden, Germany.
Lars WittAnesthesiology, KRH Klinikum Robert Koch, Gehrden, Germany.
Heiko AselmannGeneral-, Visceral and Vascular Surgery, KRH Klinikum Robert Koch, Gehrden, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robotic esophageal surgery is becoming more widely adopted. Several publications on the feasibility, short-term outcomes and technical aspects are available. Most of these articles used either the da Vinci® SI system or in newer series the Xi System. The da Vinci® X system is generally considered less suited for multiquadrant access like in esophageal surgery, hence only limited data is available. Here we describe our initial experience with 16 Ivor-Lewis robotic assisted minimally invasive esophagectomies (RAMIE) in patients with esophageal adenocarcinoma. The da Vinci® X system was installed in our department in 2019; the robotic program comprises colorectal, pancreatic and esophageal surgery. The first two patients were operated in the presence of a proctor. An operative standard was established including fluorescence angiography (Firefly®). Technical aspects with focus on the characteristics of the da Vinci® X system, operating room setup, and short-term outcomes are discussed.

Indexed as

Esophageal NeoplasmsRoboticsRobotic Surgical ProceduresEsophagectomyHumansEsophageal adenocarcinomaRobotic Assisted Minimally Invasive Esophagectomy (RAMIE)

Identifiers

PMID35815328
PMCPMC9255263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.